Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liberal versus restrictive intravenous fluid strategy in ICU patients with decompensated cirrhosis
ACTRN12615000377538Phase 3Not yet recruiting
- Sponsor
- Professor Rinaldo Bellomo
- Start
- Apr 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of albumin (human) and norepinephrine in Cirrhosis (2 arms), sponsored by Professor Rinaldo Bellomo. Primary endpoints: Change in serum creatinine, Change in NephroCheck test score and 1 more. Planned start Apr 2015; status: not yet recruiting.
02
Drugs
albumin (human)norepinephrine
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ACTRN12615000377538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000377538.